CDC’s Worst-Case Coronavirus Model: 214 Million Infected, 1.7 Million Dead (Intelligencer)

A recent CDC projection estimated that the U.S. coronavirus epidemic could infect between 160 million and 214 million people over a period of more...

‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus patients (Miami Herald)

BY BEN CONARCK APRIL 16, 2020 A team of doctors at the University of Miami won emergency federal approval to use stem cell therapy on...

FDA Authorizes Athersys (ATHX) to Initiate a Pivotal Clinical Trial!

FDA Authorizes Athersys to Initiate a Pivotal Clinical Trial Evaluating MultiStem® Cell Therapy in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome. (Editors note: a...
Biotech Stock Review, Exsosomes

Exosomes, Extracellular Vesicles, and the CoronaVirus.

Uploading a Series of Articles on Extracellular Vesicles, Including Potential Effects on the CoronaVirus and ARDS. Article #1: the basics in non-scientific terms from Larry...
Corbus Pharma, Biotech Stock Review

Adding Corbis Pharma (CRBP) $5.55 to Watch List.

Running Clinical Trials Full Steam With $46 Million Banked in Late February. Not thinly, but lightly traded. Ready, locked and loaded. All of the common...
Athersys, Biotech Stock Review

Boo Ya. Brokerage Sets $12 Price Target for Athersys (ATHX) $2.96.

A major Wall Street firm that specializes in Bio and Medtech Companies has a $12 price target out on Athersys from one of its...

Adding Organicell (BPSR) $0.02 to the Watch List.

Organicell (BBSR). New client, studying now. Thinly, thinly traded and expectedly volatile on an intra-day basis. Like what we’ve read so far about their...

Athersys (ATHX) Overview and Due Diligence links (Reddit)

I've (Dalek on Reddit) compiled a list of links that might be useful if you are disorganized like myself. If you are a newcomer...
Internet Stock Review

Immunomedics (IMMU) up 100% Today or $2 Billion in Value & Stand Down VIII:

Bear Comments from Roubini, Jim Chanos, Jim Rogers and James A. Kostohryz Don't Be That Guy in Denial! Just like people who are in denial and don't...
Biotech Stock Review, Novellus, Citius

Citius (CTXR) and Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19

Citius Signs Exclusive Option with Novellus to License Novel Stem-Cell Therapy for Acute Respiratory Distress Syndrome (ARDS) Associated with COVID-19 - Novellus's patented mRNA-based cell-reprogramming...

Latest article

Perpetua Resources (PPTA) Joins the Billion Dollar Club 

Perpetua Resources (PPTA) Joins the Billion Dollar Club Launching Institutional Gold Analyst and Gold Investor Conference1. Adding Perpetua Resources (PPTA) $13.60 to Watchlist. Antimony Heaven.2....

Blue Ocean Equities Report on Antimony.

Antimony Macro Note: Don’t expect Sb prices to pull back anytime soon! ANTIMONY MACRO NOTE On Gold Investment Conference A simply fantastic report (best in world) though...

Gold Miners Printing Record Margins – Juniors Could 10x From Here | Video

Charles Haggar, Mathieu Boisvert and Michael Gentile Will permitting reform in North America unlock trillions in hidden value? Gold and silver are soaring, but junior...